Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans

Pediatr Dermatol. 2019 May;36(3):330-334. doi: 10.1111/pde.13799. Epub 2019 Mar 18.

Abstract

Background: There have been few published randomized controlled trials for the treatment of childhood acanthosis nigricans (AN) to date.

Objective: To assess the efficacy of topical 0.1% adapalene gel compared to 0.025% tretinoin cream in the treatment of childhood AN.

Methods: An 8-week, randomized, split-neck, comparative study between topical 0.1% adapalene gel and 0.025% tretinoin cream for the treatment of neck hyperpigmentation associated with AN was performed. M index measured by a narrowband reflectance spectrophotometer and both investigator's global evaluation (IGE) and parent's global evaluation (PGE) scales were used to evaluate efficacy.

Results: There was no statistically significant difference between 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of AN-associated hyperpigmentation (P = 0.56). Mean differences in M indices between week 0 and week 8 of 0.1% adapalene and 0.025% tretinoin treatment were 24.2 ± 7.9% and 23.8 ± 8.3% improvement, respectively. Regarding treatment efficacy, 90.0% and 85.0% of participants had more than 75% improvement in IGE in 0.1% adapalene and 0.025% tretinoin treatment sides, respectively. In addition, 75.0% and 65.0% of participants had more than 75.0% improvement in PGE in 0.1% adapalene and 0.025% tretinoin treatment sides, respectively.

Limitations: Lack of histopathological evaluations.

Conclusions: We found no significant difference between topical 0.1% adapalene gel and 0.025% tretinoin in the treatment of AN.

Keywords: acanthosis nigricans; adapalene; childhood; children; topical retinoid; tretinoin.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acanthosis Nigricans / drug therapy*
  • Adapalene / therapeutic use*
  • Administration, Cutaneous
  • Adolescent
  • Child
  • Dermatologic Agents / therapeutic use*
  • Double-Blind Method
  • Female
  • Gels
  • Humans
  • Keratolytic Agents / therapeutic use*
  • Male
  • Neck
  • Skin Cream
  • Treatment Outcome
  • Tretinoin / therapeutic use*

Substances

  • Dermatologic Agents
  • Gels
  • Keratolytic Agents
  • Adapalene
  • Tretinoin